BC
Boxer Capital Portfolio holdings
AUM
$2.04B
1-Year Return
108.35%
This Quarter Return
+42.04%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.01B
AUM Growth
+$128M
(+6.8%)
Cap. Flow
-$242M
Cap. Flow
% of AUM
-12.04%
Top 10 Holdings %
Top 10 Hldgs %
57.08%
Holding
77
New
4
Increased
7
Reduced
4
Closed
25
Top Buys
| 1 |
argenx
ARGX
|
$28.5M |
| 2 |
Arvinas
ARVN
|
$25.1M |
| 3 |
Structure Therapeutics
GPCR
|
$16.3M |
| 4 |
Tango Therapeutics
TNGX
|
$10.6M |
| 5 |
Immunovant
IMVT
|
$10.5M |
Top Sells
| 1 |
Amylyx Pharmaceuticals
AMLX
|
$38.2M |
| 2 |
SPDR S&P Biotech ETF
XBI
|
$36.5M |
| 3 |
Ventyx Biosciences
VTYX
|
$29.5M |
| 4 |
Amicus Therapeutics
FOLD
|
$28.3M |
| 5 |
Exelixis
EXEL
|
$25.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Gossamer Bio
GOSS
$571M
| – | – |
-6,497,700
| Closed | -$5.41M |
|
77
Madrigal Pharmaceuticals
MDGL
$9.61B
| – | – |
-100,000
| Closed | -$14.6M |
|